Fucoidan ingredients supplier Marinova named Health & Wellness Ingredient Innovator of the Year by Global Health & Pharma Magazine
The Australian biotechnology company develops high-purity seaweed extracts for human health.
Marinova Pty Ltd. (Tasmania, Australia) won an award in Global Health & Pharma Magazine’s 2023 International Life Sciences Awards in the category of Health & Wellness Ingredient Innovator of the Year. The Australian biotechnology company develops high-purity seaweed extracts for human health, particularly fucoidan compounds, derived from select brown seaweed species and containing highly bioactive polysaccharides.
The company describes its Maritech fucoidan extracts, suited for nutritional supplements, functional foods/beverages, skincare products, and animal health products, as “the world’s only high-purity, certified-organic fucoidan extracts with global regulatory acceptance.”
In a press release, Marinova’s CEO Paul Garrott, stated, “The unrivaled quality and efficacy of Maritech organic fucoidans is based on two decades of rigorous scientific investigation and the development of an advanced proprietary extraction process.”
Kaneka Nutrients to unveil new consumer research on menopausal women at Vitafoods Europe 2024
April 26th 2024The company will reveal the results of the research that is based on live feedback from 200 menopausal women who took 200 mg per day of Kaneka Ubiquinol over two-months, monitored the effects, and recorded their observations.
Rousselot to showcase new collagen peptide research and targeted solutions at Vitafoods Europe 2024
April 25th 2024The company will be highlighting new research that demonstrates the ability of its Peptan collagen peptide brand to support sleep quality, reduce gastrointestinal discomfort, and enhance skin health, including density, hydration, and elasticity.
